FEATURED CONTRIBUTED CONTENT

Best Practices for your Next Tracking Study


Best Practices for your Next Tracking Study

The tracking study is a cornerstone of good market research. But what happens when you are faced with budget cuts, unforeseen market changes, or urgent data needs? Powerful, real-time tracking technologies can help fill these gaps and complement your traditional ATU when you need answers quickly. In this webinar, you will learn how this new […]

October 19, 2016 More Clinical »
The Election’s Impact on Pharma: Preparing for Potential Scenarios


The Election’s Impact on Pharma: Preparing for Potential Scenarios

The 2016 election will have a major impact on both federal and state healthcare policy. To be sure your organization is prepared for all the possibilities, it’s critical to understand the political dynamics that will be at play under each potential scenario—and what they will mean for the life sciences industry. In a new podcast, […]

September 13, 2016 More Clinical »
Clinical Trial Knowledge Platform: The Road To Compliance


Clinical Trial Knowledge Platform: The Road To Compliance

Regulatory scrutiny in clinical research has intensified in recent years, and there are no signs that the intensity of the regulatory environment is abating. In the context of increased outsourcing of clinical study activity to CROs, inspectors are showing an increased interest in evidence of the sponsor fulfilling their remaining oversight obligations. One step to improving the […]

August 30, 2016 More Clinical »
The New CIO Mandate in Life Sciences


The New CIO Mandate in Life Sciences

With the dramatic changes in the healthcare ecosystem due to the Affordable Care Act — combined with other trends, such as the rise of generic medicines, continued regulatory pressure and rampant consumer adoption of mobile and digital technologies — life sciences companies are under pressure to change how they do business. Forward thinkers are striving […]

September 27, 2016 More Clinical »
Piloting the Queen Mary: The Unique Challenges of Cardiovascular Outcome Studies


Piloting the Queen Mary: The Unique Challenges of Cardiovascular Outcome Studies

Cardiovascular outcome studies can be a bit like piloting the Queen Mary – multiple compartments, complex interrelated activities, difficult to launch and bring into port. To commemorate World Heart Day on September 29th, Worldwide Clinical Trial experts will highlight common challenges and key success factors, as well as design and operational conventions in cardiovascular outcome […]

September 29, 2016 More Clinical »
How Can Pharma Balance Gene Therapy’s Promise and Price?


How Can Pharma Balance Gene Therapy’s Promise and Price?

Exciting advances in science have led to developing treatment breakthroughs—such as gene scripting therapies—that could represent the first potential cures for rare diseases and other life-threatening conditions.  Gene therapies offer dramatic promise—but also come with high costs.  When viewing gene therapies and other expensive treatment options against the backdrop of an evolving healthcare landscape, several […]

November 16, 2016 More Clinical »
The ACA’s Section 1332 Waivers: Will We See More State Innovation in Health Care Reform?


The ACA’s Section 1332 Waivers: Will We See More State Innovation in Health Care Reform?

While the Affordable Care Act continues to be politically polarizing, stakeholders from across the health reform landscape are focused on effectively implementing the law and on making incremental – not radical – changes to it. The question is how such change might happen given the deep national divisions about what corrections are needed. One answer […]

September 13, 2016 More Clinical »
FEEDBACK